Business Trip

Greg Kubin & Matias Serebrinsky

Business Trip explores the frontiers of brain and mental health through conversations with founders, investors, and researchers at the intersection of neuroscience and technology.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Business Trip" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Business Trip

Episodes (66)

Mar 25th How Gilgamesh Landed a $1.2B AbbVie Deal in Psychedelics
Jan 27th Inside Philanthropy’s Role in Mental & Brain Health
Dec 19, 2025 Rick Perry on paving the way for Ibogaine in America

Business Trip

Mar 25, 2026
26½ minutes
18 MB

Jonathan Sporn (CEO + Founder of Gilgamesh Pharma) joins for a deep dive into next-gen psychedelic medicines, why duration matters for real-world clinical use, and what it takes to build these therapies the way large pharma would—culminating in a partnership with AbbVie worth up to $1.2B. In this episode, we discuss: • Why Gilgamesh is building psychedelic medicines the way large pharma would • The thesis behind short-acting psychedelics and why long-duration trips are impractical for real-world psychiatry • How Gilgamesh designs molecules backwards from clinical needs • Effective approaches to the challenges of trial designs for ps...

Business Trip

How Gilgamesh Landed a $1.2B AbbVie Deal in Psychedelics

Greg Kubin & Matias Serebrinsky

00:00 -26:25